Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH).
Behavior
Counseling
HIV
Smoking cessation
Text messaging
Tobacco
Veterans
Journal
Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
18
03
2021
revised:
09
06
2021
accepted:
11
06
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
25
11
2021
Statut:
ppublish
Résumé
Smoking rates are disproportionately high among people living with HIV. Smokers living with HIV (SLWH) are also largely unaware of the HIV-specific deleterious effects of smoking and often lack motivation and confidence in their ability to quit tobacco. To address these issues, we developed the Wellness Intervention for Smokers Living with HIV (WISH). WISH is grounded in the Information-Motivation-Behavioral Skills (IMB) Model and is designed for all SLWH, regardless of their initial motivation to quit. It follows evidence-based, best practice guidelines for nicotine dependence treatment, but is innovative in its use of a comprehensive wellness approach that addresses smoking within the context of HIV self-management including treatment adherence and engagement, stress management, substance use, and other personally relevant health behavior goals. The described randomized trial will enroll SLWH who are receiving care at Veterans Affairs (VA) medical centers and compare WISH's impact on smoking behavior to standard care services offered through the National VA Quitline and SmokefreeVET texting program. It will also assess intervention impact on markers of immune status and mortality risk. If effective, WISH could be disseminated to Veterans nationwide and could serve as a model for designing quitline interventions for other smokers who are ambivalent about quitting. The current paper outlines the rationale and methodology of the WISH trial, one of a series of studies recently funded by the National Cancer Institute to advance understanding of how to better promote smoking cessation among SLWH.
Identifiants
pubmed: 34776121
pii: S1551-7144(21)00222-6
doi: 10.1016/j.cct.2021.106486
pmc: PMC8597894
mid: NIHMS1717014
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
106486Subventions
Organisme : NCI NIH HHS
ID : R01 CA243907
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Références
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
AIDS Care. 2017 Sep;29(9):1102-1106
pubmed: 28497980
Curr HIV/AIDS Rep. 2015 Dec;12(4):413-20
pubmed: 26391516
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
AIDS. 1993 May;7(5):705-10
pubmed: 8318178
Chest. 2003 Jun;123(6):1977-82
pubmed: 12796177
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63
pubmed: 23187941
AIDS Educ Prev. 2009 Jun;21(3 Suppl):40-53
pubmed: 19537953
AIDS Behav. 2018 Jun;22(6):2026-2032
pubmed: 29030717
AIDS. 2012 May 15;26(8):1017-25
pubmed: 22382152
Clin Infect Dis. 2012 Apr;54(7):984-94
pubmed: 22337823
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):59-66
pubmed: 25118794
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
N Engl J Med. 1995 Sep 28;333(13):845-51
pubmed: 7651475
MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1513-9
pubmed: 22071589
Am J Respir Crit Care Med. 1997 Jan;155(1):72-80
pubmed: 9001292
AIDS. 2019 Apr 1;33(5):903-912
pubmed: 30649058
Addiction. 2005 Mar;100(3):299-303
pubmed: 15733243
Nicotine Tob Res. 2016 Dec;18(12):2177-2184
pubmed: 27245237
Addiction. 2019 Oct;114 Suppl 1:6-14
pubmed: 30548345
Addiction. 2009 Nov;104(11):1891-900
pubmed: 19719796
JMIR Form Res. 2020 Aug 27;4(8):e21784
pubmed: 32852278
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
AIDS Patient Care STDS. 2001 Dec;15(12):615-24
pubmed: 11788076
Addiction. 2007 Oct;102(10):1564-73
pubmed: 17854333
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
Nicotine Tob Res. 2009 May;11(5):475-80
pubmed: 19346506
J Cancer Educ. 2019 Dec;34(6):1045-1058
pubmed: 31037506
Nicotine Tob Res. 2021 Jan 22;23(2):407-410
pubmed: 32803251
JMIR Mhealth Uhealth. 2016 Aug 03;4(3):e94
pubmed: 27489247
Nicotine Tob Res. 2011 May;13(5):361-8
pubmed: 21350041
Am J Public Health. 2006 Jun;96(6):1060-5
pubmed: 16670229
AIDS Care. 2018 Feb;30(2):131-139
pubmed: 28817951
AIDS. 2013 Feb 20;27(4):563-72
pubmed: 23095314
N Engl J Med. 2012 Oct 4;367(14):1355-60
pubmed: 23034025
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 15;14(5):451-8
pubmed: 9170420
J Gen Intern Med. 2005 Dec;20(12):1142-5
pubmed: 16423106
Nicotine Tob Res. 2012 Jan;14(1):106-10
pubmed: 21669958
J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):405-414
pubmed: 31904707
Addict Res Theory. 2015 Feb;23(1):10-23
pubmed: 28529471
AIDS. 2018 Feb 20;32(4):513-521
pubmed: 29239891
Nicotine Tob Res. 2015 Aug;17(8):975-82
pubmed: 26180222
Health Psychol. 1993 Sep;12(5):399-405
pubmed: 8223364
Lancet HIV. 2018 Mar;5(3):e126-e135
pubmed: 29329763
Addict Biol. 2003 Mar;8(1):39-43
pubmed: 12745414
Nicotine Tob Res. 2003 Feb;5(1):13-25
pubmed: 12745503
Drug Alcohol Depend. 2013 Sep 1;132(1-2):352-61
pubmed: 23561823
Clin Chest Med. 1991 Dec;12(4):727-35
pubmed: 1747990
Clin Infect Dis. 2013 Mar;56(5):727-34
pubmed: 23254417
Drug Alcohol Depend. 2019 Jul 1;200:26-33
pubmed: 31082665
J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):208-15
pubmed: 22732470